The Food and Drug Administration (FDA)’s recent approval of daraxonrasib, a targeted RAS inhibitor for the most common form of pancreatic cancer, has the potential to improve short-term survival rates for advanced metastatic forms of the cancer. While not a cure, this treatment, coupled with clinical trials that can improve surgical treatment options, can provide families with more time together and ultimately, hope. [...] Cell (journal) JAMA Journal of Experimental Medicine Nature (journal) NEJM Neurology (journal) PLoS View all Journal Channels
Staff Picks Top Clipped Stories Top Hit Stories
Afghanistan News African News China News Cuba News Europe News Germany News Gulf of Mexico India/Pakistan News Iraq News View all by Location Channels [...] Expert Pitch
1-Nov-2026 at 2:45 PM EST, by UCI Health
♡
BYLINE: UCI Health
Chao Family Comprehensive Cancer Center, only National Cancer Institute-designated comprehensive cancer center based in Orange County, can offer hope for patients and families